Sex, drugs, bugs, and age: Rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 2, 2012, Pages 115-121

  Rocha, Jaime L ^a   Tuon, Felipe Francisco ^b   Johnson, James R ^c  

^a Frischmann Aisengart DASA Medicina Diagnóstica and VITA Curitiba Hospital   (Brazil)

^b HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anti bacterial agents; Drug resistance, bacterial; Escherichia coli; Fluoroquinolones; Urinary tract infections

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; NITROFURANTOIN;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT CARE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SEX RATIO; STAPHYLOCOCCUS SAPROPHYTICUS; URINARY TRACT INFECTION;

EID: 85027942080     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(12)70291-X     Document Type: Article

References (18)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113:5S-13S.
2. Warren J.W., Abrutyn E., Hebel J.R., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999, 29:745-758.
3. Bean D.C., Krahe D., Wareham D.W. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008, 7:13.
4. Astal Z., Sharif F.A., Abdallah S.A., et al. Multiresistant Escherichia coli isolated from women with communityacquired urinary tract infections in the Gaza Strip. J Chemother 2002, 14:637-638.
5. Kurutepe S., Surucuoglu S., Sezgin C., et al. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis 2005, 58:159-161.
6. McIsaac W.J., Mazzulli T., Permaul J., et al. Community-acquired antibiotic resistance in urinary isolates from adult women in Canada. Can J Infect Dis Med Microbiol 2006, 17:337-340.
7. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52:e103-e120.
8. Kiffer C.R., Mendes C., Oplustil C.P., et al. Antibiotic Resistance and Trend of Urinary Pathogens in General Outpatients from a Major Urban City. Int Braz J Urol 2007, 33:42-48.
9. Gales A.C., Sader H.S., Jones R.N. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 2002, 44:289-299.
10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4 2009, National Committee for Clinical Laboratory Standards, National Committee for Clinical Laboratory Standards, Wayne.
11. Johnson J.R., Tiu F.S., Stamm W.E. Direct antimicrobial susceptibility testing for acute urinary tract infections in women. J Clin Microbiol 1995, 33:2316-2323.
12. Laupland K.B., Ross T., Pitout J.D., et al. Community-onset urinary tract infections: a population-based assessment. Infection 2007, 35:150-153.
13. Alos J.I. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enferm Infecc Microbiol Clin 2005, 23:S3-S8.
14. Gupta K., Hooton T.M., Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001, 135:41-50.
15. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study. Int J Antimicrob Agents 2003, 22(Suppl 2):49-52.
16. Katsarolis I., Poulakou G., Athanasia S., et al. Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment. Int J Antimicrob Agents 2010, 35:62-67.
17. Oteo J., Lazaro E., de Abajo F.J., et al. Antimicrobial-resistant invasive Escherichia coli. Spain. Emerg Infect Dis 2005, 11:546-553.
18. Talan D.A., Krishnadasan A., Abrahamian F.M., et al. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazoleand fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008, 47:1150-1158.